Minato-ku, Japan

Tomio Furuta



 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Tokyo, JP (1998 - 2008)
  • Minato-ku, JP (2014)

Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Tomio Furuta

Introduction

Tomio Furuta is a notable inventor based in Minato-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for breast cancer resistance proteins. With a total of 4 patents to his name, Furuta's work has the potential to impact cancer treatment significantly.

Latest Patents

One of Furuta's latest patents is focused on a BCRP/ABCG2 inhibitor, which is designed to combat breast cancer resistance. This innovative drug contains an acrylonitrile derivative or a salt thereof as its active ingredient. The invention aims to provide a drug that effectively inhibits the breast cancer resistance protein, showcasing Furuta's commitment to advancing medical science.

Career Highlights

Throughout his career, Tomio Furuta has worked with prominent companies such as Yakult Honsha Co., Ltd. and Daiichi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to hone his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Furuta has collaborated with esteemed colleagues, including Takashi Yaegashi and Seigo Sawada. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Tomio Furuta's contributions to the field of pharmaceuticals, particularly in developing cancer treatment options, highlight his role as a significant inventor. His work continues to inspire future innovations in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…